Cargando…

Association between prostate-specific antigen change over time and prostate cancer recurrence risk: A joint model

BACKGROUND: Prostate specific antigen (PSA) is an important biomarker to monitor patients after treated with radiation therapy (RT). The aim of this study is to evaluate the relationship between the PSA data and prostate cancer recurrence using the joint modeling. METHODS: This historical cohort stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ali Mohammadpour, Reza, Alizadeh, Ahad, Barzegar, Mohammad-Reza, Akbarzadeh Pasha, Abazar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Babol University of Medical Sciences 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442453/ https://www.ncbi.nlm.nih.gov/pubmed/32874441 http://dx.doi.org/10.22088/cjim.11.3.324

Ejemplares similares

Comparative analysis of resected prostate weight in diabetic and non-diabetic benign prostatic hyperplasia Patients
por: Moudi, Emadoddin, et al.
Publicado: (2017)

Radiation dose-response (a Bayesian model) in the radiotherapy of the localized prostatic adenocarcinoma: the reliability of PSA slope changes as a response surrogate endpoint
por: Mohammadpour, Reza Ali, et al.
Publicado: (2019)

Prostate-Specific Antigen and Prostate-Specific Antigen Velocity as Threshold Indicators in (11)C-Acetate PET/CTAC Scanning for Prostate Cancer Recurrence
por: Dusing, Reginald W., et al.
Publicado: (2014)

Potential Child Abuse Screening in Emergency Department; a Diagnostic Accuracy Study
por: Dinpanah, Hossein, et al.
Publicado: (2017)

Prostate specific antigen change after administration of nimotuzumab in prostate cancer
por: Chaiyasit, Kamon, et al.
Publicado: (2013)

Association of Diet With Prostate Specific Antigen and Prostate Volume
por: Shirazi, Mehdi, et al.
Publicado: (2014)

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
por: Ben Jemaa , Awatef, et al.
Publicado: (2010)

Prostate specific antigen /
Publicado: (2001)

Overexpression of claspin promotes docetaxel resistance and is associated with prostate‐specific antigen recurrence in prostate cancer
por: Babasaki, Takashi, et al.
Publicado: (2021)

Evaluation of prostatic cancer prevalence in patients with prostatic-specific antigen between 4 and 10 and normal digital rectal examination
por: Tadayon, Farhad, et al.
Publicado: (2016)

The effect of the frequency and duration of prostate specific antigen (PSA) measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer
por: Paller, CJ, et al.
Publicado: (2013)

Defining Prostatic Vascular Pedicle Recurrence and the Anatomy of Local Recurrence of Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography
por: Dundee, Philip, et al.
Publicado: (2022)

Pretreatment prostate specific antigen doubling time as prognostic factor in prostate cancer patients
por: Zharinov, Gennady M., et al.
Publicado: (2017)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
por: Teoh, Jeremy YC, et al.
Publicado: (2017)

Prostate-Specific Antigen Nadir and Time to Prostate-Specific Antigen Nadir Following Maximal Androgen Blockade Independently Predict Prognosis in Patients with Metastatic Prostate Cancer
por: Hong, Seok Young, et al.
Publicado: (2012)

The Specific Choice of Transrectal Ultrasound-Guided Prostate Biopsy Scheme Based on Prostate Specific Antigen and Prostate Specific Antigen Density
por: Chen, Yue, et al.
Publicado: (2019)

The Predictive Role of Prostate-Specific Antigen Changes Following Transurethral Resection of the Prostate for Patients with Localized Prostate Cancer
por: Wu, Chun-Te, et al.
Publicado: (2020)

Prostate-Specific Antigen Density and Gleason Score Predict Adverse Pathologic Features in Patients with Clinically Localized Prostate Cancer
por: Nowroozi, Mohammad Reza, et al.
Publicado: (2016)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
por: Shahab, Ahmad Anies, et al.
Publicado: (2013)

Production and Characterization of Monoclonal Antibodies against Human Prostate Specific Antigen
por: Bayat, Ali Ahmad, et al.
Publicado: (2015)

Association of time to prostate-specific antigen nadir and logarithm of prostate-specific antigen velocity after progression in metastatic prostate cancer with prior primary androgen deprivation therapy
por: Teoh, Jeremy YC, et al.
Publicado: (2017)

Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy
por: Pendleton, John M, et al.
Publicado: (2008)

Prostate-specific antigen density predicts favorable pathology and biochemical recurrence in patients with intermediate-risk prostate cancer
por: Kang, Ho Won, et al.
Publicado: (2016)

The Spontaneous Remission of Recurrent Lymph Node Metastatic Prostate Cancer With Lowering Serum Prostate-Specific Antigen Level
por: Katano, Atsuto, et al.
Publicado: (2022)

Prostate-Specific Antigen Mass and Free Prostate-Specific Antigen Mass for Predicting the Prostate Volume of Korean Men With Biopsy-Proven Benign Prostatic Hyperplasia
por: Park, Tae Yong, et al.
Publicado: (2013)

Old habits die hard; does early urinary catheter removal affect kidney size, bacteriuria and UTI after renal transplantation?
por: Akbari, Roghayeh, et al.
Publicado: (2016)

Updates of prostate cancer staging: Prostate-specific membrane antigen
por: Sathianathen, Niranjan J, et al.
Publicado: (2016)

Advice About Screening for Prostate Cancer With Prostate-Specific Antigen
por: Jean-Pierre, Gannel
Publicado: (2017)

Re: Prognosis of prostate cancer and prostate - specific antigen levels
por: Joob, Beuy, et al.
Publicado: (2019)

Prostate-specific membrane antigen-mediated theragnostics in prostate cancer
por: Jeong, Seung-hwan, et al.
Publicado: (2021)

Adaptive sequential plan-on-plan optimization during prostate-specific antigen response guided radiotherapy of recurrent prostate cancer
por: Jóhannesson, Vilberg, et al.
Publicado: (2021)

The neutrophil-to-lymphocyte ratio at the prostate-specific antigen nadir predicts the time to castration-resistant prostate cancer
por: Iwamoto, Genta, et al.
Publicado: (2021)

Age-specific reference ranges of prostate-specific antigen in the elderly of Amirkola: A population-based study
por: Reza, Hosseini Seyed, et al.
Publicado: (2021)

Age-specific prostate specific antigen and prostate specific antigen density values in a community-based Indian population
por: Ganpule, Arvind P., et al.
Publicado: (2007)

Xanthogranulomatous pyelonephritis combined with emphysematous pyelonephritis: A rare case report
por: Moudi, Emadoddin, et al.
Publicado: (2021)

Effect of Heamolysis on Prostate-Specific Antigen
por: Sağlam, Hasan S., et al.
Publicado: (2012)

Comment on the discovery of prostate specific antigen
por: Lue, Tom F.
Publicado: (2014)

Free Prostate-Specific Antigen Provides More Precise Data on Benign Prostate Volume Than Total Prostate-Specific Antigen in Korean Population
por: Choi, Hoon, et al.
Publicado: (2013)

Machine learning methods can more efficiently predict prostate cancer compared with prostate-specific antigen density and prostate-specific antigen velocity
por: Nitta, Satoshi, et al.
Publicado: (2019)

The effect of urethral catheterization on the level of prostate-specific antigen
por: Izadpanahi, Mohammad Hossein, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_k369eqdru48ttrf8a5ft10kp97